$10.69
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
KalVista Pharma (KALV) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestKalVista Pharma (NASDAQ:KALV) Stock Quotes, Forecast and News Summary
KalVista Pharma Stock (NASDAQ: KALV) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 348.30K |
| Day Range | - - - |
| 52 Wk Range | 7.21 - 16.88 |
| Market Cap | $460.55M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 37 |
| Short Interest | 15.09% |
| Days to Cover | 18.98 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About KalVista Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, developmen...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy KalVista Pharma (KALV) stock?
You can purchase shares of KalVista Pharma (NASDAQ:KALV) through any online brokerage.
Who are KalVista Pharma (KALV) competitors?
Other companies in KalVista Pharma’s space includes: Valneva (NASDAQ:VALN), Inozyme Pharma (NASDAQ:INZY), Larimar Therapeutics (NASDAQ:LRMR), Altimmune (NASDAQ:ALT) and Sage Therapeutics (NASDAQ:SAGE).
What is the forecast, or price target, for KalVista Pharma (KALV) stock?
KalVista Pharma has a consensus price target of $26.00.
What is the current price for KalVista Pharma (KALV)?
The stock price for KalVista Pharma (NASDAQ: KALV) is $10.69 last updated September 18, 2024 at 4:00 PM EDT.
Does KalVista Pharma (KALV) pay a dividend?
There are no upcoming dividends for KalVista Pharma.
When is KalVista Pharma (NASDAQ:KALV) reporting earnings?
KalVista Pharma’s Q2 earnings are confirmed for Thursday, December 5, 2024.
Is KalVista Pharma (KALV) going to split?
There is no upcoming split for KalVista Pharma.
What sector and industry does KalVista Pharma (KALV) operate in?
KalVista Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.